GenEmbryomics Limited (XGEN)

GenEmbryomics was planning to go public, but the IPO was withdrawn on Apr 23, 2025.

IPO Price

$4.75

Shares Offered

1,095,000

Deal Size

$5.20M

GenEmbryomics Financials Overview

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '24 Jun 30, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Operating Income	-1.81	-1.81	-0.52
Net Income	-1.98	-1.98	-0.52

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Jun '24 Jun 30, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Cash & Investments	0.04	0.04	0.1
Total Debt	0.71	0.71	0.27
Net Cash (Debt)	-0.67	-0.67	-0.16
Net Cash Growth	-	-	-

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '24 Jun 30, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Operating Cash Flow	-1.17	-1.17	-0.46
Free Cash Flow	-1.17	-1.17	-0.46
Free Cash Flow Growth	-	-	-